Literature DB >> 11059834

Differential expression of protein kinase C subtypes during ginsenoside Rh2-lnduced apoptosis in SK-N-BE(2) and C6Bu-1 cells.

Y S Kim1, S H Jin, Y H Lee, J D Park, S I Kim.   

Abstract

We examined the modulation of protein kinase C (PKC) subtypes during apoptosis induced by ginsenoside Rh2 (G-Rh2) in human neuroblastoma SK-N-BE(2) and rat glioma C6Bu-1 cells. Apoptosis induced by G-Rh2 in both cell lines was confirmed, as indicated by DNA fragmentation and in situ strand breaks, and characteristic morphological changes. During apoptosis induced by G-Rh2 in SK-N-BE(2) cells, PKC subtypes alpha, beta and gamma were progressively increased with prolonged treatment, whereas PKC delta increased transiently at 3 and 6 h and PKC epsilon was gradually down-regulated after 6 h following the treatment. On the other hand, PKC subtype zeta markedly increased at 24 h when maximal apoptosis was achieved. In C6Bu-1 cells, no significant changes in PKC subtypes alpha, gamma, delta, epsilon and zeta were observed during apoptosis induced by G-Rh2. These results suggest the evidence for a possible role of PKC subtype in apoptosis induced by G-Rh2 in SK-N-BE(2) cells but not in C6Bu-1 cells, and raise the possibility that G-Rh2 may induce apoptosis via different pathways interacting with or without PKC in different cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059834     DOI: 10.1007/bf02976583

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  6 in total

1.  Three new triterpenoids from Panax ginseng exhibit cytotoxicity against human A549 and Hep-3B cell lines.

Authors:  Hai-Ying Ma; Hui-Yuan Gao; Jian Huang; Bo-Hang Sun; Bo Yang
Journal:  J Nat Med       Date:  2012-04-12       Impact factor: 2.343

Review 2.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.

Authors:  Martin Michaelis; Florian Rothweiler; Nadine Löschmann; Mohsen Sharifi; Taravat Ghafourian; Jindrich Cinatl
Journal:  Oncotarget       Date:  2015-07-10

4.  Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).

Authors:  M Tatsuka; M Maeda; T Ota
Journal:  Jpn J Cancer Res       Date:  2001-11

5.  A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells.

Authors:  A Muscella; C Vetrugno; F P Fanizzi; C Manca; S A De Pascali; S Marsigliante
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

6.  p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells.

Authors:  Xiao-Xi Guo; Yang Li; Chao Sun; Dan Jiang; Ying-Jia Lin; Feng-Xie Jin; Seung-Ki Lee; Ying-Hua Jin
Journal:  Protein Cell       Date:  2014-03-13       Impact factor: 14.870

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.